{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:23:53Z","timestamp":1790601833691,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05693-z","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T09:38:13Z","timestamp":1764581893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020\u20132021"],"prefix":"10.1186","volume":"25","author":[{"given":"Adama","family":"Gansane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casimir","family":"Tarama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Lingani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siaka","family":"Debe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Tiendrebeogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Kinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladari","family":"Sagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama","family":"Ganou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toussaint","family":"Rouamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salif","family":"Sombie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Some","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraphine","family":"Kiendrebeogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massa A.","family":"Bonko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Tougri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Kompaore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Eddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Culzean","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Bajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Pierre-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rosillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruviben S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McCaffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz M.","family":"Plucinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Valea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah F.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"5693_CR1","unstructured":"Minist\u00e8re de la Sant\u00e9 du Burkina Faso. Annuaire Statistique de la Sant\u00e9. Ouagadougou, Burkina Faso, 2023."},{"key":"5693_CR2","unstructured":"Minist\u00e8re de la Sant\u00e9. Annuaire Statistique de la sant\u00e9. Ouagadougou, Burkina Faso, 2021."},{"key":"5693_CR3","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"5693_CR4","unstructured":"Minist\u00e8re de la Sant\u00e9. Directives nationales pour la prise en charge du paludisme. Ouagadougou, Burkina Faso, 2021."},{"key":"5693_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-021-03745-8","volume":"20","author":"A Abamecha","year":"2021","unstructured":"Abamecha A, Yilma D, Adissu W, Yewhalaw D, Abdissa A. Efficacy and safety of artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis. Malar J. 2021;20:213.","journal-title":"Malar J"},{"key":"5693_CR6","doi-asserted-by":"publisher","first-page":"1058660","DOI":"10.3389\/fcimb.2022.1058660","volume":"12","author":"B Abuaku","year":"2023","unstructured":"Abuaku B, Boateng P, Peprah NY, Asamoah A, Duah-Quashie NO, Matrevi SA, et al. Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana. Front Cell Infect Microbiol. 2023;12:1058660.","journal-title":"Front Cell Infect Microbiol"},{"key":"5693_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12936-022-04350-z","volume":"21","author":"A Assefa","year":"2022","unstructured":"Assefa A, Mohammed H, Anand A, Abera A, Sime H, Minta AA, et al. Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia. Malar J. 2022;21:359.","journal-title":"Malar J"},{"key":"5693_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12936-019-2864-1","volume":"18","author":"M Warsame","year":"2019","unstructured":"Warsame M, Hassan AM, Hassan AH, Jibril AM, Khim N, Arale AM, et al. High therapeutic efficacy of artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated falciparum malaria in Somalia. Malar J. 2019;18:231.","journal-title":"Malar J"},{"key":"5693_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/trstmh\/trz009","volume":"113","author":"A Uwimana","year":"2019","unstructured":"Uwimana A, Penkunas MJ, Nisingizwe MP, Warsame M, Umulisa N, Uyizeye D, et al. Efficacy of artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial. Trans R Soc Trop Med Hyg. 2019;113:312\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5693_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4269\/ajtmh.18-0115","volume":"99","author":"JC Ebenebe","year":"2018","unstructured":"Ebenebe JC, Ntadom G, Ambe J, Wammanda R, Jiya N, Finomo F, et al. Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children ten years following adoption as first-line antimalarials. Am J Trop Med Hyg. 2018;99:649\u201364.","journal-title":"Am J Trop Med Hyg"},{"key":"5693_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12936-021-03585-6","volume":"20","author":"A Gansan\u00e9","year":"2021","unstructured":"Gansan\u00e9 A, Moriarty LF, M\u00e9nard D, Yerbanga I, Ouedraogo E, Sondo P, et al. Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017\u20132018. Malar J. 2021;20:48.","journal-title":"Malar J"},{"key":"5693_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01525-23","volume":"68","author":"PR Dimbu","year":"2024","unstructured":"Dimbu PR, Labuda S, Ferreira CM, Caquece F, Andr\u00e9 K, Pembele G, et al. Therapeutic response to four artemisinin-based combination therapies in Angola, 2021. Antimicrob Agents Chemother. 2024;68:e0152523.","journal-title":"Antimicrob Agents Chemother"},{"key":"5693_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01949-20","volume":"65","author":"PR Dimbu","year":"2021","unstructured":"Dimbu PR, Horth R, C\u00e2ndido ALM, Ferreira CM, Caquece F, Garcia LEA, et al. Continued low efficacy of artemether-lumefantrine in Angola in 2019. Antimicrob Agents Chemother. 2021;65:e01949-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"5693_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12936-024-04850-0","volume":"23","author":"MA Mawuli","year":"2024","unstructured":"Mawuli MA, Amoah LE, Cui L, Quashie NB, Afrane YA. Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana. Malar J. 2024;23:40.","journal-title":"Malar J"},{"key":"5693_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","volume":"12","author":"C Amaratunga","year":"2012","unstructured":"Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851\u20138.","journal-title":"Lancet Infect Dis"},{"key":"5693_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis"},{"key":"5693_CR17","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva: World Health Organization; 2020."},{"key":"5693_CR18","doi-asserted-by":"crossref","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana J-LM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","DOI":"10.1038\/s41591-020-1005-2"},{"key":"5693_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337\u201345.","journal-title":"Lancet Infect Dis"},{"key":"5693_CR20","doi-asserted-by":"crossref","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C. Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","DOI":"10.4269\/ajtmh.14-0031"},{"key":"5693_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis. 2017;17:174\u201383.","journal-title":"Lancet Infect Dis"},{"key":"5693_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-023-04645-9","volume":"22","author":"CW Tarama","year":"2023","unstructured":"Tarama CW, Sor\u00e9 H, Siribi\u00e9 M, D\u00e9b\u00e9 S, Kinda R, Ganou A, et al. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso. Malar J. 2023;22:213.","journal-title":"Malar J"},{"key":"5693_CR23","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy, vol. 85. Geneva: World Health Organization; 2009."},{"key":"5693_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/tmi.12313_2","volume":"19","author":"WHO","year":"2014","unstructured":"WHO. Severe Malaria. Trop Med Int Health. 2014;19:7\u2013131.","journal-title":"Trop Med Int Health"},{"key":"5693_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056677","volume":"8","author":"NW Lucchi","year":"2013","unstructured":"Lucchi NW, Narayanan J, Karell MA, Xayavong M, Kariuki S, DaSilva AJ, et al. Molecular diagnosis of malaria by photo-induced electron transfer fluorogenic primers: PET-PCR. PLoS ONE. 2013;8:e56677.","journal-title":"PLoS ONE"},{"key":"5693_CR26","volume-title":"Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: report of a virtual meeting","author":"WHO","year":"2021","unstructured":"WHO. Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: report of a virtual meeting. Geneva: World Health Organization; 2021."},{"key":"5693_CR27","doi-asserted-by":"publisher","first-page":"02474","DOI":"10.1128\/AAC.02474-17","volume":"62","author":"E Talundzic","year":"2018","unstructured":"Talundzic E, Ravishankar S, Kelley J, Patel D, Plucinski M, Schmedes S, et al. Next-generation sequencing and bioinformatics protocol for malaria drug resistance marker surveillance. Antimicrob Agents Chemother. 2018;62:02474\u2013517.","journal-title":"Antimicrob Agents Chemother"},{"key":"5693_CR28","doi-asserted-by":"publisher","first-page":"22979","DOI":"10.1038\/s41598-021-02452-3","volume":"11","author":"JN McCaffery","year":"2021","unstructured":"McCaffery JN, Nace D, Herman C, Singh B, Sompwe EM, Nkoli PM, et al. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients in the DRC enrolled from 2017 to 2018. Sci Rep. 2021;11:22979.","journal-title":"Sci Rep"},{"key":"5693_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/cpt.1531","volume":"106","author":"P Chotsiri","year":"2019","unstructured":"Chotsiri P, Denoeud-Ndam L, Baudin E, Guindo O, Diawara H, Attaher O, et al. Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether-lumefantrine for uncomplicated malaria. Clin Pharmacol Ther. 2019;106:1299\u2013309.","journal-title":"Clin Pharmacol Ther"},{"key":"5693_CR30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1086\/522985","volume":"45","author":"I Zongo","year":"2007","unstructured":"Zongo I, Dorsey G, Rouamba N, Dokomajilar C, S\u00e9r\u00e9 Y, Rosenthal PJ, et al. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007;45:1453\u201361.","journal-title":"Clin Infect Dis"},{"key":"5693_CR31","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.35.68.20849","volume":"35","author":"I Zongo","year":"2020","unstructured":"Zongo I, Compaor\u00e9 YD, Niki\u00e9ma F, Zongo M, Barry N, Som\u00e9 FA, et al. Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change. Pan Afr Med J. 2020;35:68.","journal-title":"Pan Afr Med J"},{"key":"5693_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(22)00593-X","volume":"23","author":"KB Beshir","year":"2023","unstructured":"Beshir KB, Muwanguzi J, Nader J, Mansukhani R, Traore A, Gamougam K, et al. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. Lancet Infect Dis. 2023;23:361\u201370.","journal-title":"Lancet Infect Dis"},{"key":"5693_CR33","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/jac\/dkad260","volume":"78","author":"W-Y Chu","year":"2023","unstructured":"Chu W-Y, Dorlo TP. Pyronaridine: a review of its clinical pharmacology in the treatment of malaria. J Antimicrob Chemother. 2023;78:2406\u201318.","journal-title":"J Antimicrob Chemother"},{"key":"5693_CR34","unstructured":"WHO. Multiple first-line therapies as part of the response to antimalarial drug resistance. Geneva: World Health Organization; 2024."},{"key":"5693_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/1475-2875-13-363","volume":"13","author":"AT Mori","year":"2014","unstructured":"Mori AT, Ngalesoni F, Norheim OF, Robberstad B. Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malar J. 2014;13:363.","journal-title":"Malar J"},{"key":"5693_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S1473-3099(23)00209-8","volume":"23","author":"B Ogutu","year":"2023","unstructured":"Ogutu B, Yeka A, Kusemererwa S, Thompson R, Tinto H, Toure AO, et al. Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial. Lancet Infect Dis. 2023;23:1051\u201361.","journal-title":"Lancet Infect Dis"},{"key":"5693_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12936-024-04844-y","volume":"23","author":"E Kokori","year":"2024","unstructured":"Kokori E, Olatunji G, Akinboade A, Akinoso A, Egbunu E, Aremu SA, et al. Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts. Malar J. 2024;23:25.","journal-title":"Malar J"},{"key":"5693_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722\u201332.","journal-title":"N Engl J Med"},{"key":"5693_CR39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5693_CR40","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","volume":"389","author":"S Mihreteab","year":"2023","unstructured":"Mihreteab S, Platon L, Berhane A, Stokes BH, Warsame M, Campagne P, et al. Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea. N Engl J Med. 2023;389:1191\u2013202.","journal-title":"N Engl J Med"},{"key":"5693_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04981-4","volume":"23","author":"C Schreidah","year":"2024","unstructured":"Schreidah C, Giesbrecht D, Gashema P, Young NW, Munyaneza T, Muvunyi CM, et al. Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda. Malar J. 2024;23:150.","journal-title":"Malar J"},{"key":"5693_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12936-023-04796-9","volume":"22","author":"CW Tarama","year":"2023","unstructured":"Tarama CW, Sor\u00e9 H, Siribi\u00e9 M, D\u00e9b\u00e9 S, Kinda R, Nonkani WG, et al. Assessing the histidine-rich protein 2\/3 gene deletion in Plasmodium falciparum isolates from Burkina Faso. Malar J. 2023;22:363.","journal-title":"Malar J"},{"key":"5693_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3201\/eid2803.211499","volume":"28","author":"E Rogier","year":"2022","unstructured":"Rogier E, McCaffery JN, Nace D, Svigel SS, Assefa A, Hwang J, et al. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions from persons with symptomatic malaria infection in Ethiopia, Kenya, Madagascar, and Rwanda. Emerg Infect Dis. 2022;28:608\u201316.","journal-title":"Emerg Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05693-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05693-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05693-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:52:41Z","timestamp":1767707561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-025-05693-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5693"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05693-z","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}